Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2023

20.01.2023 | Original Article

Clinical and Genetic Characteristics of BCG Disease in Chinese Children: a Retrospective Study

verfasst von: Yuyuan Zeng, Wenjing Ying, Wenjie Wang, Jia Hou, Luyao Liu, Bijun Sun, Xiaoying Hui, Yu Gu, Xiaoyu Song, Xiaochuan Wang, Jinqiao Sun

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Summarize the characteristics of a large cohort of BCG disease and compare differences in clinical characteristics and outcomes among different genotypes and between primary immunodeficiency disease (PID) and patients without identified genetic etiology.

Methods

We collected information on patients with BCG disease in our center from January 2015 to December 2020 and divided them into four groups: chronic granulomatous disease (CGD), Mendelian susceptibility to mycobacterial disease (MSMD), severe combined immunodeficiency disease (SCID), and gene negative group.

Results

A total of 134 patients were reviewed, and most of them had PID. A total of 111 (82.8%) patients had 18 different types of pathogenic gene mutations, most of whom (91.0%) were classified with CGD, MSMD, and SCID. CYBB was the most common gene mutation (52/111). BCG disease behaves differently in individuals with different PIDs. Significant differences in sex (P < 0.001), age at diagnosis (P = 0.013), frequency of recurrent fever (P = 0.007), and vaccination-homolateral axillary lymph node enlargement (P = 0.039) and infection severity (P = 0.006) were noted among the four groups. The CGD group had the highest rate of males and the oldest age at diagnosis. The MSMD group had the highest probability of disseminated infection (48.3%). The course of anti-tuberculosis treatment and the survival time between patients with PID and without identified genetic etiology were similar.

Conclusion

Greater than 80% of BCG patients have PID; accordingly, gene sequencing should be performed in patients with BCG disease for early diagnosis. BCG disease behaves differently in patients with different types of PID. Patients without identified genetic etiology had similar outcomes to PID patients, which hints that they may have pathogenic gene mutations that need to be discovered.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat BCG vaccine. WHO position paper. Releve epidemiologique hebdomadaire. 2004;79(4):27–38. BCG vaccine. WHO position paper. Releve epidemiologique hebdomadaire. 2004;79(4):27–38.
2.
Zurück zum Zitat National Health Commission Procedures and Instructions for Children's Immunization under the National Immunization Program (Version 2021). Chin J Viral Dis. 2021;11(4):241–5. National Health Commission Procedures and Instructions for Children's Immunization under the National Immunization Program (Version 2021). Chin J Viral Dis. 2021;11(4):241–5.
3.
4.
Zurück zum Zitat Wang J, Wu QS, Jiang MB, Xu ZH. Two cases of disseminated BCG disease following vaccination in the same family: case reports and review of the literature in China. Hum Vaccin Immunother. 2021;17(5):1382–6.CrossRefPubMed Wang J, Wu QS, Jiang MB, Xu ZH. Two cases of disseminated BCG disease following vaccination in the same family: case reports and review of the literature in China. Hum Vaccin Immunother. 2021;17(5):1382–6.CrossRefPubMed
5.
Zurück zum Zitat Grange JM. Complications of Bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health. 1998;1(2):84–8.PubMed Grange JM. Complications of Bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health. 1998;1(2):84–8.PubMed
6.
Zurück zum Zitat Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Vaccine. 2015;33(41):5470–4.CrossRefPubMedPubMedCentral Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Vaccine. 2015;33(41):5470–4.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ying W, Sun J, Liu D, Hui X, Yu Y, Wang J, et al. Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study. PLoS ONE. 2014;9(4): e94485.CrossRefPubMedPubMedCentral Ying W, Sun J, Liu D, Hui X, Yu Y, Wang J, et al. Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study. PLoS ONE. 2014;9(4): e94485.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ong RYL, Chan SB, Chew SJ, Liew WK, Thoon KC, Chong CY, et al. Disseminated Bacillus-Calmette-Guérin infections and primary immunodeficiency disorders in Singapore: a single center 15-year retrospective review. Int J Infect Dis. 2020;97:117–25.CrossRefPubMed Ong RYL, Chan SB, Chew SJ, Liew WK, Thoon KC, Chong CY, et al. Disseminated Bacillus-Calmette-Guérin infections and primary immunodeficiency disorders in Singapore: a single center 15-year retrospective review. Int J Infect Dis. 2020;97:117–25.CrossRefPubMed
9.
Zurück zum Zitat Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41.CrossRefPubMedPubMedCentral Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated Bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis. 1997;24(6):1139–46.CrossRefPubMed Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated Bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis. 1997;24(6):1139–46.CrossRefPubMed
11.
12.
Zurück zum Zitat Jensen KJ, Biering-Sørensen S, Ursing J, Kofoed PL, Aaby P, Benn CS. Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality: three randomised controlled trials in Guinea-Bissau. BMJ Glob Health. 2020;5(3): e001873.CrossRefPubMedPubMedCentral Jensen KJ, Biering-Sørensen S, Ursing J, Kofoed PL, Aaby P, Benn CS. Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality: three randomised controlled trials in Guinea-Bissau. BMJ Glob Health. 2020;5(3): e001873.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Alfawaz TS, Alshehri M, Alshahrani D. BCG related complications: a single center, prospective observational study. Int J Pediatr Adolesc Med. 2015;2(2):75–8.CrossRefPubMedPubMedCentral Alfawaz TS, Alshehri M, Alshahrani D. BCG related complications: a single center, prospective observational study. Int J Pediatr Adolesc Med. 2015;2(2):75–8.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect. 2012;64(6):543–54.CrossRefPubMedPubMedCentral Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect. 2012;64(6):543–54.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Khalili N, Mohammadzadeh I, Khalili N, Heredia RJ, Zoghi S, Boztug K, et al. BCGitis as the primary manifestation of chronic granulomatous disease. IDCases. 2021;23: e01038.CrossRefPubMed Khalili N, Mohammadzadeh I, Khalili N, Heredia RJ, Zoghi S, Boztug K, et al. BCGitis as the primary manifestation of chronic granulomatous disease. IDCases. 2021;23: e01038.CrossRefPubMed
16.
Zurück zum Zitat Soyak Aytekin E, Keskin A, Tan C, Yalçın E, Dogru D, Ozcelik U, et al. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: a single-centre study. Scand J Immunol. 2021;94(4): e13084.CrossRefPubMed Soyak Aytekin E, Keskin A, Tan C, Yalçın E, Dogru D, Ozcelik U, et al. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: a single-centre study. Scand J Immunol. 2021;94(4): e13084.CrossRefPubMed
17.
Zurück zum Zitat Al Waili B, Al Mufarajii N, Al Hashmi S, Al Ajmi A, Al SN. Bacillus Calmette-Guérin vaccine-related complications in children in Oman. Ann Saudi Med. 2021;41(1):24–30.CrossRefPubMedPubMedCentral Al Waili B, Al Mufarajii N, Al Hashmi S, Al Ajmi A, Al SN. Bacillus Calmette-Guérin vaccine-related complications in children in Oman. Ann Saudi Med. 2021;41(1):24–30.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020;8(4):1371–86.CrossRefPubMed Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020;8(4):1371–86.CrossRefPubMed
19.
Zurück zum Zitat Bolursaz MR, Lotfian F, Velayati AA. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital. Allergol Immunopathol. 2017;45(4):356–61.CrossRef Bolursaz MR, Lotfian F, Velayati AA. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital. Allergol Immunopathol. 2017;45(4):356–61.CrossRef
Metadaten
Titel
Clinical and Genetic Characteristics of BCG Disease in Chinese Children: a Retrospective Study
verfasst von
Yuyuan Zeng
Wenjing Ying
Wenjie Wang
Jia Hou
Luyao Liu
Bijun Sun
Xiaoying Hui
Yu Gu
Xiaoyu Song
Xiaochuan Wang
Jinqiao Sun
Publikationsdatum
20.01.2023
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2023
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01422-2

Weitere Artikel der Ausgabe 4/2023

Journal of Clinical Immunology 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.